Denik Pharma Glycotide

​Denik Pharm’s Glycotide is a semaglutide-based peptide supplement designed to regulate blood sugar levels and support weight loss. Semaglutide, an incretin mimetic similar to the GLP-1 hormone, stimulates insulin release post-meal, lowers blood glucose, curbs appetite, and aids in weight management.

Benefits:

• Blood Sugar Control: Enhances insulin production and reduces hepatic glucose output, beneficial for individuals with type 2 diabetes or prediabetes.
• Weight Loss: Suppresses appetite and promotes satiety, contributing to weight reduction.
• Cardiovascular Health: Lowers the risk of stroke, heart attack, and mortality in adults with type 2 diabetes and existing heart conditions.

Dosage:

Initiate with a 500 mcg subcutaneous injection weekly, gradually increasing to 1 mg weekly over 20-50 weeks. After this period, a maintenance dose is recommended to prevent rebound effects.

Side Effects and Contraindications:

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain, and reduced appetite.
• Endocrine: Potential risk of thyroid tumors.
• Pancreatic: Risk of pancreatitis; monitor for severe abdominal pain.
• Hypoglycemia: Especially when combined with other glucose-lowering agents.
• Renal: Possibility of kidney injury; regular kidney function assessments are advised.
• Vision: Report any changes in vision to a healthcare provider.

Denik Pharm ensures the integrity of Glycotide through its Temporect Pro™ packaging, which is both temperature and shockproof, preserving the product’s efficacy during transportation and storage.

For more information or to purchase Glycotide, visit Denik Pharm’s official website.

Please consult a registered healthcare professional before starting Glycotide to ensure it’s appropriate for your individual health needs.